0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Escitalopram, Problem-Solving Therapy, and Poststroke Depression—Reply

Robert G. Robinson, MD; Ricardo E. Jorge, MD; Stephan Arndt, PhD
JAMA. 2008;300(15):1757-1759. doi:10.1001/jama.300.15.1758-b.
Text Size: A A A
Published online

Extract

In Reply: Drs Schulte-Herbrüggen and Röpke question whether the treatment with escitalopram may have provided some neuroprotective function through mechanisms such as neurogenesis or increase in neuropeptides that have been identified in animal models of neuropathology. We only assessed activities of daily living and cognitive function. We did not find any significant time × treatment interaction in Functional Independence Measure scores over the course of the year. We also found no significant differences in recurrent stroke or hospitalization for cardiovascular illness. It is possible, however, that longer-term follow-up may show lower differential rates of recurrence of stroke or cardiovascular morbidity or mortality.1

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

October 15, 2008
Olaf Schulte-Herbrüggen, MD; Stefan Röpke, MD
JAMA. 2008;300(15):1757-1759. doi:10.1001/jama.300.15.1757-a.
October 15, 2008
Michael Dettling, MD; Carolin Opgen-Rhein, MD; Ion Anghelescu, MD
JAMA. 2008;300(15):1757-1759. doi:10.1001/jama.300.15.1757-b.
October 15, 2008
Jeffrey Lacasse, PhD; Jonathan Leo, PhD
JAMA. 2008;300(15):1757-1759. doi:10.1001/jama.300.15.1757-c.
October 15, 2008
Alice Rasmussen, MD; Jamal A. Hanash, MD; Per Bech, MD
JAMA. 2008;300(15):1757-1759. doi:10.1001/jama.300.15.1758-a.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();